Show simple item record

AuthorKaló ,Zoltán
AuthorAlabbadi ,Ibrahim
AuthorAl Ahdab ,Ola Ghaleb
AuthorAlowayesh ,Maryam
AuthorElmahdawy ,Mahmoud
AuthorAl-Saggabi ,Abdulaziz H
AuthorTanzi ,Vito Luigi
AuthorAl-Badriyeh ,Daoud
AuthorAlsultan ,Hamad S
AuthorAli ,Faleh Mohamed Hussain
AuthorElsisi ,Gihan H
AuthorAkhras ,Kasem S
AuthorVokó ,Zoltán
AuthorKanavos ,Panos
Available date2024-04-30T05:47:45Z
Publication Date2015
Publication NameExpert Review of Pharmacoeconomics and Outcomes Research
ResourceScopus
Identifierhttp://dx.doi.org/10.1586/14737167.2015.1048227
ISSN14737167
URIhttp://hdl.handle.net/10576/54473
AbstractIntroduction: External price referencing (EPR) is applied frequently to control pharmaceutical prices. Our objective was to analyse how EPR is used in Middle Eastern (ME) countries and to compare the price corridor for original pharmaceuticals to non-pharmaceutical services not subjected to EPR. Methods: We conducted a survey on EPR regulations and collected prices of 16 patented pharmaceuticals and 14 non-pharmaceutical services in seven Middle Eastern (ME) countries. Maximum and minimum prices of each pharmaceutical and non-pharmaceutical technology were compared to mean prices in the countries studied by using market exchange rates. Influencing factors of pharmaceutical prices were assessed by multivariate linear regression analysis. Results: The average price corridor is narrower for pharmaceuticals (-39.8%; +35.9%) than for outpatient and hospital services (-81.7%; +96.3%). Conclusion: Our analysis revealed the importance of population size and EPR implementation on drug price levels; however, EPR results in higher pharmaceutical prices in lower-income countries compared to non-pharmaceutical services.
Languageen
PublisherTaylor and Francis Ltd
Subjectcross-national price comparison
external reference pricing
international society of pharmacoeconomics and outcomes research
Middle East countries
pharmaceutical pricing
price corridor for pharmaceuticals
TitleImplications of external price referencing of pharmaceuticals in Middle East countries
TypeArticle
Pagination993-998
Issue Number6
Volume Number15
dc.accessType Abstract Only


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record